My research is focused on clinical outcomes in the area of Neuromuscular disorders such as Cerebral Palsy and Spina Bifida as well as investigations of various gait (movement) disorders. My clinical practice involves working with a wide array of patients, many of which have neuromuscular disorders involving severe spasticity. Spasticity occurs when there is a defect in the Central Nervous System that causes certain muscles to continuously tighten and contract. Treatments for this debilitating condition involve the use of botulinum toxin (Botox) which is the injection into the muscle which blocks the nerves from causing the muscles to contract. One area of my research and clinical practice involves investigating the functional outcomes of children who receive Botox treatments for spasticity.
Publications
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study,Dosage et sécurité à long terme de l'onabotulinumtoxinA : Une étude prospective et observationnelle Canadian Journal of Neurological Sciences Wein, T. and Jog, M. and Bhogal, M. and Dhani, S. and Miller, R. and Ismail, F. and Beauchamp, R. and Trentin, G. DOI: 10.1017/cjn.2019.238 2019
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment Canadian Journal of Neurological Sciences Jog, M. and Wein, T. and Bhogal, M. and Dhani, S. and Miller, R. and Ismail, F. and Beauchamp, R. and Trentin, G. DOI: 10.1017/cjn.2016.262 2016
Long-term outcome after selective dorsal rhizotomy in children with spastic cerebral palsy Child's Nervous System Ailon, T. and Beauchamp, R. and Miller, S. and Mortenson, P. and Kerr, J.M. and Hengel, A.R. and Steinbok, P. DOI: 10.1007/s00381-015-2614-9 2015
Corrigendum to "Classification of midfoot break using multi-segment foot kinematics and pedobarography" [Gait Posture 39 (1) (2014) 1-6] Gait and Posture Maurer, J.D. and Ward, V. and Mayson, T.A. and Davies, K.R. and Alvarez, C.M. and Beauchamp, R.D. and Black, A.H. DOI: 10.1016/j.gaitpost.2014.02.004 2014
Classification of midfoot break using multi-segment foot kinematics and pedobarography Gait and Posture Maurer, J.D. and Ward, V. and Mayson, T.A. and Davies, K.R. and Alvarez, C.M. and Beauchamp, R.D. and Black, A.H. DOI: 10.1016/j.gaitpost.2013.08.015 2014
Reliability of retrospective assignment of gross motor function classification system scores Developmental Neurorehabilitation Mayson, T.A. and Ward, V. and Davies, K.R. and Maurer, J. and Alvarez, C. and Beauchamp, R. and Black, A. DOI: 10.3109/17518423.2012.755575 2013
A kinematic description of dynamic midfoot break in children using a multi-segment foot model Gait and Posture Maurer, J.D. and Ward, V. and Mayson, T.A. and Davies, K.R. and Alvarez, C.M. and Beauchamp, R.D. and Black, A.H. DOI: 10.1016/j.gaitpost.2012.12.002 2013
Botulinum toxin-a use in paediatric hypertonia: Canadian practice patterns Canadian Journal of Neurological Sciences Fehlings, D. and Narayanan, U. and Andersen, J. and Beauchamp, R. and Gorter, J.W. and Kawamura, A. and Kiefer, G. and Mason, M. and McCormick, A. and Mesterman, R. and Switzer, L. and Watt, J. DOI: 10.1017/S0317167100014049 2012
Inter-observer and intra-observer agreement in the radiographic diagnosis of avascular necrosis of the femoral head following slipped capital femoral epiphysis Journal of Children's Orthopaedics Davidson, D. and Ghag, A. and Beauchamp, R.D. and Tredwell, S.J. and Mulpuri, K. DOI: 10.1007/s11832-010-0273-7 2010
Classification of idiopathic toe walking based on gait analysis: Development and application of the ITW severity classification Gait and Posture Alvarez, C. and De Vera, M. and Beauchamp, R. and Ward, V. and Black, A. DOI: 10.1016/j.gaitpost.2006.10.011 2007
Treatment of idiopathic clubfoot utilizing botulinum A toxin: A new method and its short-term outcomes Journal of Pediatric Orthopaedics Alvarez, C.M. and Tredwell, S.J. and Keenan, S.P. and Beauchamp, R.D. and Choit, R.L. and Sawatzky, B.J. and De Vera, M.A. DOI: 10.1097/01.bpo.0000149861.50400.db 2005
Hip joint subluxation after selective dorsal rhizotomy for spastic cerebral palsy Journal of Neurosurgery Hicdonmez, T. and Steinbok, P. and Beauchamp, R. and Sawatzky, B. 2005
Spinal deformities after selective dorsal rhizotomy for spastic cerebral palsy Journal of Neurosurgery Steinbok, P. and Hicdonmez, T. and Sawatzky, B. and Beauchamp, R. and Wickenheiser, D. DOI: 10.3171/jns.2005.102.2.0363 2005
Paraparesis caused by an angiolipomatous hamartoma in an adolescent with Proteus syndrome and scoliosis. Case report Journal of Neurosurgery White, N.J. and Cochrane, D.D. and Beauchamp, R. 2005
Diagnosing Musculoskeletal Pain in Children Canadian Medical Association Journal 07/2001
Rheumatology: 16. Diagnosing musculoskeletal pain in children CMAJ Malleson, P.N. and Beauchamp, R.D. 2001
Radical Hip Release in Spina Bifida Patients—an Aid to Improving Mobility Spina Bifida Richard D. Beauchamp and Bonita J. Sawatzky and Carol E. King and Beverly Irwin DOI: 10.1007/978-4-431-68373-5_70 1999
A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy Developmental Medicine and Child Neurology Steinbok, P. and Reiner, A.M. and Beauchamp, R. and Armstrong, R.W. and Cochrane, D.D. DOI: 10.1111/j.1469-8749.1997.tb07407.x 1997
Management of pulseless pink hand in pediatric supracondylar fractures of humerus Journal of Pediatric Orthopaedics Sabharwal, S. and Tredwell, S.J. and Beauchamp, R.D. and Mackenzie, W.G. and Jakubec, D.M. and Cairns, R. and LeBlanc, J.G. DOI: 10.1097/01241398-199705000-00007 1997
Upper Body Exercise Capacity in Youth with Spina Bifida Adapted Physical Activity Quarterly Kenneth Coutts and Donald McKenzie and Christine Loock and Richard Beauchamp and Robert Armstrong DOI: 10.1123/apaq.10.1.22 01/1993
Ground reactions forces of children with clubfeet Journal of Biomechanics Bonita J. Sawatzky and David J. Sanderson and Richard D. Beauchamp and A.Ross Outerbridge DOI: 10.1016/0021-9290(92)90395-h 07/1992
Selective functional posterior rhizotomy for treatment of spastic cerebral palsy in children Pediatric Neurosurgery Steinbok, P. and Reiner, A. and Beauchamp, R.D. and Cochrane, D.D. and Keyes, R. DOI: 10.1159/000120639 1992
Osteomyelitis of the pelvis due to Fusobacterium nucleatum Canadian Journal of Surgery Beauchamp, R.D. and Cimolai, N. 1991
Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children Arthritis & Rheumatism Allen, R.C. and Gross, K.R. and Laxer, R.M. and Malleson, P.N. and Beauchamp, R.D. and Petty, R.E. DOI: 10.1002/art.1780290808 1986
Total replacement arthroplasty of elbow in rheumatoid arthritis Canadian Journal of Surgery Harder, D.H. and Beauchamp, R.D. 1977
Research
Current Projects One research project that I am currently involved in is a prospective observational database designed to collect data on patient reported outcomes in individuals using Botox for medical reasons. Botulinum toxin (Botox) is used medically to reduce spasticity of muscles, however, the outcomes of this are not measureable through radiographs or other clinical exams. Clinicians are able to see if the botox has had its effect (i.e. if the limb is no longer spastic), however, whether or not the botox is helping the patient functionally remains unknown. Therefore, it is the objective of this study to determine the functional outcomes of Botox when used for medical purposes. In order to achieve this, 50 Specialists across Canada are involved in administering functional outcome questionnaires (SF-12 Health and Well-being Questionnaire and the Global Rating of Change Questionnaire) to their patients who are receiving botox treatments.
A second research project that I am currently involved in is investigating the treatment pattern of Cerebral Palsy with Botulinum Toxin (Botox) in Canada. It is a Practice Assessment Program designed as a prospective audit of physician practice patterns. Many physicians in Canada are currently using Botox as a treatment for Cerebral Palsy but little is known about which physicians are prescribing it and which types of patients they are prescribing its use for. The objective of this study is to gather information on practice patterns related to treatment of Botox injection for Cerebral Palsy and to explore the relationship between the patterms of cerebral palsy indication treatment with the use of Botox injections.
Honours & Awards
Richmond Cerebral Palsy Award, American Academy Cerebral Palsy in Child Developmental Medicine, Portland, Oregon, with Dr. Paul Steinbok, September 1997.
Diplomat, American Board of Orthopaedic Surgery, 1980.
Special Recognition for 25 years service from “The Centre for Child Development” Surrey B.C., May 3, 2009
Educational Award of Excellence with Distinction. Children & Women’s Health Centre of British Columbia, May 23, 2003
Merit Award, Fraternity To Help Guatemalan Children, April 28, 2001
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
The team, led by researchers from BC Children’s Hospital Research Institute and the University of British Columbia, is the first in Canada to combine these two techniques to identify and test a drug for a young patient's tumour in time for their treatment.
Congratulations to the investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Fall 2024 Project Grant competition!
The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.
New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.
Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.